Skip to main content
main-content
Top

04-04-2022 | COVID-19 | News

News in brief

Study demonstrates negative impact of COVID-19 on rheumatology training, research

Author: Claire Barnard

share
SHARE
print
PRINT
insite
SEARCH

medwireNews: The COVID-19 pandemic has had a considerable impact on rheumatology training and research opportunities, suggest findings from an international survey study by the COVID-19 Global Rheumatology Alliance.

In their survey of 302 rheumatology trainees from 33 countries, Arundathi Jayatilleke (Temple University School of Medicine, Philadelphia, Pennsylvania, USA) and team found that 45% of respondents reported an increase in non-rheumatology clinical work during the pandemic, with just over half of these people continuing rheumatology work during redeployment.

The researchers say that the COVID-19 pandemic had a “substantial impact” on training experiences, with 79% of trainees reporting an effect on outpatient clinical work and 55% reporting an effect on didactic education.

The majority (72%) of respondents participated in research before the pandemic, but 46% said they had experienced a change in research experience due to COVID-19, and 47% reported difficulties in keeping up with research goals. A third of respondents said the pandemic had a negative impact on research opportunities in the following year, while 16% reported an increase in research opportunities.

“These findings highlight the importance of curriculum and workforce assessments, along with reforms to ensure that rheumatology trainees have the support and training required to adapt to the changes brought about by the pandemic,” conclude the researchers in Rheumatology Advances in Practice.

medwireNews is an independent medical news service provided by Springer Healthcare Ltd. © 2022 Springer Healthcare Ltd, part of the Springer Nature Group

4 April 2022: The coronavirus pandemic is affecting all healthcare professionals across the globe. Medicine Matters’ focus, in this difficult time, is the dissemination of the latest data to support you in your research and clinical practice, based on the scientific literature. We will update the information we provide on the site, as the data are published. However, please refer to your own professional and governmental guidelines for the latest guidance in your own country.

Rheumatol Adv Pract 2022; doi:10.1093/rap/rkac001

share
SHARE
print
PRINT

Rituximab and rheumatology practice in the COVID-19 era

How can rheumatologists respond to the challenges associated with rituximab use during the pandemic?

New additions to the Adis Journal Club

A selection of topical peer-reviewed articles from the Adis journals, curated by the editors.

Related content

18-01-2022 | COVID-19 | Feature | Article

COVID-19: Lessons learned for rheumatology practice

How has the pandemic changed clinical practice and what learnings can rheumatologists take forward to improve patient care?